Phase I Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of OBI-858 for Treatment of Glabellar Lines

This study demonstrated that OBI-858 is well tolerated and showed preliminary efficacy. Overall, the OBI-858 has a clinically favorable profile of safety and efficacy that warrants proceeding to the next studies.

Authors

Institutions

Publication Details

Journal
Dermatology and Therapy
Published
2024-11-25
DOI
https://doi.org/10.1007/s13555-024-01309-7
Citations
1
Primary Topic
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.37
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase I Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of OBI-858 for Treatment of Glabellar Lines

C N Ou, Tim-Mo Chen, Chih‐Hung Lee
1 citations
Dermatology and Therapy
Botulinum Toxin and Related Neurological Disorders
0.37
article

Phase I Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of OBI-858 for Treatment of Glabellar Lines

C N Ou, Tim-Mo Chen, Chih‐Hung Lee
article en
1 citations

Abstract

This study demonstrated that OBI-858 is well tolerated and showed preliminary efficacy. Overall, the OBI-858 has a clinically favorable profile of safety and efficacy that warrants proceeding to the next studies.

Dermatology and TherapyVol. 14(12)
Tri-Service General Hospital (TW), Chang Gung University (TW), Kaohsiung Chang Gung Memorial Hospital (TW), National Defense Medical Center (TW)
Good health and well-being
Openalex Percentile: Top 33%
Botulinum Toxin and Related Neurological Disorders
0.37
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Phase I Trial to Assess the Safety, Tolerability, and Preliminary Efficacy of OBI-858 for Treatment of Glabellar Lines — C N Ou, Tim-Mo Chen, et al. · Dermatology and Therapy (2024) | TGRS Research Map | TGRS